As emerging drug candidates become increasingly complex and pressure for rapid clinical entry intensifies, early planning of quantity, quality, and supply of API is more important than ever. The webinar will outline best practices for establishing a robust supply route, optimizing synthetic processes, and selecting appropriate regulatory starting materials to enable efficient GMP production.
Featured Speakers:
- Aaron Dumas – Senior Director, Process Chemistry at Pharmaron
- Brett Cooper – Senior Director, Analytical and Material Science at Pharmaron
Moderator:
- Peter Shapland – Senior Director, Drug Substance Commercialisation at Pharmaron
Date: 7 May 2026
Time: 17:00 CET
Format: Webinar